Actively Recruiting
Hypertension Registry: Study of Primary and Secondary Hypertension Phenotypes, Complications, and Treatment Personalization
Led by Moroccan Society of Cardiology · Updated on 2025-01-24
10000
Participants Needed
5
Research Sites
52 weeks
Total Duration
On this page
Sponsors
M
Moroccan Society of Cardiology
Lead Sponsor
F
F&C Clinical Trials
Collaborating Sponsor
AI-Summary
What this Trial Is About
Researchers are studying the quality of primary healthcare for patients with arterial hypertension in Morocco, focusing on the disease's prevalence, types, complications, and treatment personalization. This observational cohort study aims to improve understanding and management of hypertension by comparing current data with past results and other North African countries. The study highlights key aspects like timely care, accessibility, and adherence to clinical guidelines. The study uses a remote electronic registry to collect anonymous medical data from both primary care and hospital settings. Trained investigators will standardize blood pressure measurements to reduce errors. Data gathered will include clinical details, treatments, complications, anthropometric measurements, blood pressure readings using validated devices or ambulatory monitoring, and metabolic assessments such as blood glucose and cholesterol levels. Cardiovascular complications will also be tracked. The follow-up period targets one year to observe complications related to hypertension. Participants aged 18 and older with diagnosed hypertension will provide informed consent before inclusion. Researchers will analyze the prevalence and geographic spread of hypertension, its various types, and associated complications at the study start. Data collection includes physical measurements, laboratory tests, and complication records. The study will compare findings to previous years and other countries to identify care gaps and progress. The total participation spans from initial inclusion through a one-year follow-up to monitor outcomes and inform better prevention and treatment strategies.
CONDITIONS
Brief Title
Hypertension Registry: Study of Primary and Secondary Hypertension Phenotypes, Complications, and Treatment Personalization.
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Individuals aged over 18 years
- Patients with blood pressure higher than 140 mmHg systolic and/or 90 mmHg diastolic in consultation or hospital
- Patients with blood pressure higher than 135/85 mmHg at home or in ambulatory blood pressure measurements
- Patients who have agreed and signed the informed consent
- Patients with legal residency status in Morocco
You will not qualify if you...
- Patients without diagnosis of hypertension
- Patients under 18 years old
- Patients refusing to sign informed consent
- Patients with illegal residency status in Morocco
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - 1 year
Participants who undergo routine care are observed to collect information on hypertension phenotypes, complications, and treatment outcomes.
Trial Site Locations
Total: 5 locations
1
Moroccan Society of Cardiology
Meknes, Morocco, Morocco
Actively Recruiting
2
Moroccan Society of Cardiology
Casablanca, Morocco
Actively Recruiting
3
UM6SSP
Casablanca, Morocco
Actively Recruiting
4
Ibn Sina Hospital Center
Rabat, Morocco
Actively Recruiting
5
Mohamed V Military Hospital
Rabat, Morocco
Actively Recruiting
Research Team
F
F&C Clinical Trials
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here